Principles and application of in-vitro drug pharmacokinetic simulation systems controlled by stepwise method
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-09-01
著者
-
OHYA Satoshi
Biological Research Laboratories, Sankyo Co., Ltd.
-
Ohya Satoshi
Biological Research Laboratories Sankyo Co. Ltd.
-
Shimada Kaoru
Tokyo Senbai Hospital
-
Shimada Kaoru
Tokyo Metropolitan Yoikuin Geriatrics Hospital
-
KUMAMOTO Yoshiaki
Sapporo Medical University
関連論文
- Synthesis in Vitro Antifungal Activities of Novel Triazole Antifungal Agent CS-758
- CD8^+ T Lymphocyte Counts as an Adjunctive Predictor of Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome
- In Vitro and Ex Vivo Anti-human Immunodeficiency Virus (HIV) Activities of a New Water-Soluble HIV Protease Inhibitor, R-87366,Containing (2S, 3S)-3-Amino-2-hydroxy-4-phenylbutanoic Acid
- Oral Vancomycin Hydrochloride Therapy for Postoperative Methicillin-Cephem-Resistant Staphylococcus aureus Enteritis
- Synthesis and Antifungal Activities of R-102557 and Related Dioxane-Triazole Derivatives
- Principles and application of in-vitro drug pharmacokinetic simulation systems controlled by stepwise method
- Inhibitory Activity to Protein Prenylation and Antifungal Activity of Zaragozic Acid D3, a Potent Inhibitor of Squalene Synthase Produced by the Fungus, Mollisia sp. SANK 10294
- Shock in Patients with Disseminated Intravascular Coagulation (DIC) : SYMPOSIUM ON TREATMENT OF SHOCK